Haemonetics Corporation has grown revenue 4.5% a year over three years and 8.9% a year over five, with earnings per share compounding at −2.8%. Revenue growth, 3-year annual rate: +4.5% (Medical Devices median +9.2%). Revenue growth, 5-year rate: +8.9%, growth has slowed since the five-year average. Earnings per share, 3-year rate: −2.8%, earnings lagged revenue: the growth is costing something. Years of annual history on file: 18, FY2009 to FY2026, as filed.

HAEHaemonetics Corporation

HealthcareUSD

$106.58

$47.6752 weeks$108.76

Is it growing?

Is HAE growing?

Haemonetics Corporation has grown revenue 4.5% a year over three years and 8.9% a year over five, with earnings per share compounding at −2.8%.

+4.5%

Revenue growth, 3-year annual rate · Medical Devices median +9.2% · growing slowly · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +8.9%
Revenue growth, 5-year rate · +4.5% over three · growth has slowed since the five-year average
Earnings per share, 3-year rate: −2.8%
Earnings per share, 3-year rate · revenue +4.5% · earnings lagged revenue: the growth is costing something
Years of annual history on file: 18
Years of annual history on file · FY2009 to FY2026, as filed